West Pharmaceutical Services (WST) EBT Margin (2009 - 2026)

West Pharmaceutical Services has disclosed EBT Margin across 18 years of filings, most recently posting 20.65% for Q2 2026.

• In Q2 2026, EBT Margin rose 16.0% year-over-year to 20.65%; the TTM figure through Jun 2026 stood at 20.85% (up 68.0% YoY), while the FY2025 annual figure was 19.55%, down 69.0% from the prior year.
• EBT Margin came in at 20.65% for Q2 2026 at West Pharmaceutical Services, down from 21.32% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 29.46% in Q2 2022 to a low of 15.83% in Q1 2025.
• Average EBT Margin over 5 years is 21.58%, with a median of 21.34% recorded in 2025.
• Year-over-year, EBT Margin sank 673 bps in 2022 and surged 549 bps in 2026.
• Over 5 years, EBT Margin stood at 18.16% in 2022, then grew by 27 bps to 22.98% in 2023, then fell by 4 bps to 22.02% in 2024, then declined by 9 bps to 20.06% in 2025, then increased by 3 bps to 20.65% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 20.65% in Q2 2026, 21.32% in Q1 2026, and 20.06% in Q4 2025.